SCHEMBL43591

SCHEMBL43591

[CH2]C/C=C/C[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43592 1.00
SCHEMBL11264582 1.00
SCHEMBL1114099 0.85
SCHEMBL1114100 0.85
SCHEMBL11474234 0.85
SCHEMBL8648395 0.85
SCHEMBL8787 0.78
SCHEMBL2518190 0.78
SCHEMBL7361807 0.78
SCHEMBL6641066 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 358 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4338316-A PROSTAGLANDIN F SERIES ANALOGUES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1982-07-06 US claimed
EP-0010360-B1 PROSTANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-06-02 EP claimed
EP-0010360-A1 Prostane derivatives, processes for their preparation and their pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP claimed
US-12024595-B2 Polymer composition BASF SE (DE) 2024-07-02 US disclosed
US-20240174664-A1 BICYCLIC AMINES AS CDK2 INHIBITORS INCYTE CORPORATION 2024-05-30 US disclosed
WO-2024107686-A1 MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2024-05-23 WO disclosed
US-11981671-B2 Bicyclic pyrazolyl amines as CDK2 inhibitors INCYTE CORPORATION (US) 2024-05-14 US disclosed
US-11976073-B2 Bicyclic amines as CDK2 inhibitors INCYTE CORPORATION (US) 2024-05-07 US disclosed
US-11912722-B2 Tricyclic heteroaryl compounds as sting activators INCYTE CORPORATION (US) 2024-02-27 US disclosed
US-11866432-B2 Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors INCYTE CORPORATION (US) 2024-01-09 US disclosed
WO-2023250430-A1 BICYCLIC AMINE CDK12 INHIBITORS INCYTE CORPORATION (US) 2023-12-28 WO disclosed
US-4590268-A HALOACYLATION WITH PHOSGENE, AMINATION CIBA-GEIGY CORPORATION (US) 1986-05-20 US disclosed
US-4584265-A TRIAZINE COMPOUNDS SUBSTITUTED WITH STERICALLY HINDERED PHENOL=ANDPOLYALKYLPIPERIDINE GROUPS CIBA-GEIGY AG (CH) 1986-04-22 US disclosed
US-4560709-A CONTAINING DUAL CATALYST OF AROMATIC IODONIUM SALT AND AROMATIC OXY KETONE CIBA GEIGY CORPORATION (US) 1985-12-24 US disclosed
US-4558131-A PHOTOSTABILIZERS CIBA-GEIGY AG (CH) 1985-12-10 US disclosed
US-4556714-A LIGHT STABILIZER FOR POLYMERS CIBA-GEIGY CORPORATION (US) 1985-12-03 US disclosed
US-4540732-A LUBRICANT AND POLYMER STABILIZERS CIBA-GEIGY CORPORATION (US) 1985-09-10 US disclosed
US-4338316-A PROSTAGLANDIN F SERIES ANALOGUES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1982-07-06 US disclosed
EP-0010360-B1 PROSTANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-06-02 EP disclosed
EP-0010360-A1 Prostane derivatives, processes for their preparation and their pharmaceutical compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP disclosed